Topical application of oxifulvic acid suppresses the cutaneous immune response in mice

The antiinflammatory activity of topically applied coal‐derived fulvic acids (called oxifulvic acid) at 4.5% and 9% was compared with that of diclofene sodium at 1% and betamethasone at 0.1% in a murine model of contact hypersensitivity. Mice were sensitised with dinitrofluorobenzene and challenged...

Full description

Saved in:
Bibliographic Details
Published in:Drug development research 2001-05, Vol.53 (1), p.29-32
Main Authors: Van Rensburg, Constance E.J., Malfeld, Susan C.K., Dekker, Johan
Format: Article
Language:English
Subjects:
betamethasone
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
diclofene sodium
Medical sciences
mice
oxifuvic acid
Pharmacology. Drug treatments
topical antiinflammatory
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3966-3d2d232e74cb03ee507aca7b1dca4cb81a1f20173270a4bd1d58b94ec9361b6f3
cites cdi_FETCH-LOGICAL-c3966-3d2d232e74cb03ee507aca7b1dca4cb81a1f20173270a4bd1d58b94ec9361b6f3
container_end_page 32
container_issue 1
container_start_page 29
container_title Drug development research
container_volume 53
creator Van Rensburg, Constance E.J.
Malfeld, Susan C.K.
Dekker, Johan
description The antiinflammatory activity of topically applied coal‐derived fulvic acids (called oxifulvic acid) at 4.5% and 9% was compared with that of diclofene sodium at 1% and betamethasone at 0.1% in a murine model of contact hypersensitivity. Mice were sensitised with dinitrofluorobenzene and challenged 6 days later by application to the dorsal surface of the right ear. The inflamed ears of the mice were then treated topically, and the thickness of the ears was measured daily. Oxifulvic acid at both concentrations compared favourably with both diclofene sodium and betamethasone in suppressing the cutaneous inflammatory response. Oxifulvic acid possesses antiinflammatory properties and may be of clinical benefit in the treatment of inflammatory skin conditions in humans. Drug Dev. Res. 53:29–32, 2001. © 2001 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ddr.1166
format article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ddr_1166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DDR1166</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3966-3d2d232e74cb03ee507aca7b1dca4cb81a1f20173270a4bd1d58b94ec9361b6f3</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMoWKvgT8jBg5et-dhuNkdpdRWKitT2GLJJFqP7EZJdbf-9KS3ixdMMMw_vMA8AlxhNMELkRms_wTjLjsAII54nhHB-DEaIMJKklONTcBbCB0IYp3k-Aqtl56ySNZTO1bHpbdfCroLdxlZD_WUVlMpqGAbnvAnBBNi_G6iGXramGwK0TTO0Bsad69pgoG1hY5U5ByeVrIO5ONQxeLu_W84eksVz8Ti7XSSK8ixLqCaaUGJYqkpEjZkiJpVkJdZKxlGOJa4IwowShmRaaqyneclTozjNcJlVdAyu97nKdyF4UwnnbSP9VmAkdj5E9CF2PiJ6tUedDPHhystW2fCHz3k8H7Fkj33b2mz_jRPz-esh9sDb0JvNLy_9p8gYZVOxfirEuqCrdL0k4oX-ALvLfsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Topical application of oxifulvic acid suppresses the cutaneous immune response in mice</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Van Rensburg, Constance E.J. ; Malfeld, Susan C.K. ; Dekker, Johan</creator><creatorcontrib>Van Rensburg, Constance E.J. ; Malfeld, Susan C.K. ; Dekker, Johan</creatorcontrib><description>The antiinflammatory activity of topically applied coal‐derived fulvic acids (called oxifulvic acid) at 4.5% and 9% was compared with that of diclofene sodium at 1% and betamethasone at 0.1% in a murine model of contact hypersensitivity. Mice were sensitised with dinitrofluorobenzene and challenged 6 days later by application to the dorsal surface of the right ear. The inflamed ears of the mice were then treated topically, and the thickness of the ears was measured daily. Oxifulvic acid at both concentrations compared favourably with both diclofene sodium and betamethasone in suppressing the cutaneous inflammatory response. Oxifulvic acid possesses antiinflammatory properties and may be of clinical benefit in the treatment of inflammatory skin conditions in humans. Drug Dev. Res. 53:29–32, 2001. © 2001 Wiley‐Liss, Inc.</description><identifier>ISSN: 0272-4391</identifier><identifier>EISSN: 1098-2299</identifier><identifier>DOI: 10.1002/ddr.1166</identifier><identifier>CODEN: DDREDK</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>betamethasone ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; diclofene sodium ; Medical sciences ; mice ; oxifuvic acid ; Pharmacology. Drug treatments ; topical antiinflammatory</subject><ispartof>Drug development research, 2001-05, Vol.53 (1), p.29-32</ispartof><rights>Copyright © 2001 Wiley‐Liss, Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3966-3d2d232e74cb03ee507aca7b1dca4cb81a1f20173270a4bd1d58b94ec9361b6f3</citedby><cites>FETCH-LOGICAL-c3966-3d2d232e74cb03ee507aca7b1dca4cb81a1f20173270a4bd1d58b94ec9361b6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1089507$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Rensburg, Constance E.J.</creatorcontrib><creatorcontrib>Malfeld, Susan C.K.</creatorcontrib><creatorcontrib>Dekker, Johan</creatorcontrib><title>Topical application of oxifulvic acid suppresses the cutaneous immune response in mice</title><title>Drug development research</title><addtitle>Drug Dev. Res</addtitle><description>The antiinflammatory activity of topically applied coal‐derived fulvic acids (called oxifulvic acid) at 4.5% and 9% was compared with that of diclofene sodium at 1% and betamethasone at 0.1% in a murine model of contact hypersensitivity. Mice were sensitised with dinitrofluorobenzene and challenged 6 days later by application to the dorsal surface of the right ear. The inflamed ears of the mice were then treated topically, and the thickness of the ears was measured daily. Oxifulvic acid at both concentrations compared favourably with both diclofene sodium and betamethasone in suppressing the cutaneous inflammatory response. Oxifulvic acid possesses antiinflammatory properties and may be of clinical benefit in the treatment of inflammatory skin conditions in humans. Drug Dev. Res. 53:29–32, 2001. © 2001 Wiley‐Liss, Inc.</description><subject>betamethasone</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>diclofene sodium</subject><subject>Medical sciences</subject><subject>mice</subject><subject>oxifuvic acid</subject><subject>Pharmacology. Drug treatments</subject><subject>topical antiinflammatory</subject><issn>0272-4391</issn><issn>1098-2299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LAzEQhoMoWKvgT8jBg5et-dhuNkdpdRWKitT2GLJJFqP7EZJdbf-9KS3ixdMMMw_vMA8AlxhNMELkRms_wTjLjsAII54nhHB-DEaIMJKklONTcBbCB0IYp3k-Aqtl56ySNZTO1bHpbdfCroLdxlZD_WUVlMpqGAbnvAnBBNi_G6iGXramGwK0TTO0Bsad69pgoG1hY5U5ByeVrIO5ONQxeLu_W84eksVz8Ti7XSSK8ixLqCaaUGJYqkpEjZkiJpVkJdZKxlGOJa4IwowShmRaaqyneclTozjNcJlVdAyu97nKdyF4UwnnbSP9VmAkdj5E9CF2PiJ6tUedDPHhystW2fCHz3k8H7Fkj33b2mz_jRPz-esh9sDb0JvNLy_9p8gYZVOxfirEuqCrdL0k4oX-ALvLfsQ</recordid><startdate>200105</startdate><enddate>200105</enddate><creator>Van Rensburg, Constance E.J.</creator><creator>Malfeld, Susan C.K.</creator><creator>Dekker, Johan</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200105</creationdate><title>Topical application of oxifulvic acid suppresses the cutaneous immune response in mice</title><author>Van Rensburg, Constance E.J. ; Malfeld, Susan C.K. ; Dekker, Johan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3966-3d2d232e74cb03ee507aca7b1dca4cb81a1f20173270a4bd1d58b94ec9361b6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>betamethasone</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>diclofene sodium</topic><topic>Medical sciences</topic><topic>mice</topic><topic>oxifuvic acid</topic><topic>Pharmacology. Drug treatments</topic><topic>topical antiinflammatory</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Rensburg, Constance E.J.</creatorcontrib><creatorcontrib>Malfeld, Susan C.K.</creatorcontrib><creatorcontrib>Dekker, Johan</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Drug development research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Rensburg, Constance E.J.</au><au>Malfeld, Susan C.K.</au><au>Dekker, Johan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topical application of oxifulvic acid suppresses the cutaneous immune response in mice</atitle><jtitle>Drug development research</jtitle><addtitle>Drug Dev. Res</addtitle><date>2001-05</date><risdate>2001</risdate><volume>53</volume><issue>1</issue><spage>29</spage><epage>32</epage><pages>29-32</pages><issn>0272-4391</issn><eissn>1098-2299</eissn><coden>DDREDK</coden><abstract>The antiinflammatory activity of topically applied coal‐derived fulvic acids (called oxifulvic acid) at 4.5% and 9% was compared with that of diclofene sodium at 1% and betamethasone at 0.1% in a murine model of contact hypersensitivity. Mice were sensitised with dinitrofluorobenzene and challenged 6 days later by application to the dorsal surface of the right ear. The inflamed ears of the mice were then treated topically, and the thickness of the ears was measured daily. Oxifulvic acid at both concentrations compared favourably with both diclofene sodium and betamethasone in suppressing the cutaneous inflammatory response. Oxifulvic acid possesses antiinflammatory properties and may be of clinical benefit in the treatment of inflammatory skin conditions in humans. Drug Dev. Res. 53:29–32, 2001. © 2001 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1002/ddr.1166</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0272-4391
ispartof Drug development research, 2001-05, Vol.53 (1), p.29-32
issn 0272-4391
1098-2299
language eng
recordid cdi_crossref_primary_10_1002_ddr_1166
source Wiley-Blackwell Read & Publish Collection
subjects betamethasone
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
diclofene sodium
Medical sciences
mice
oxifuvic acid
Pharmacology. Drug treatments
topical antiinflammatory
title Topical application of oxifulvic acid suppresses the cutaneous immune response in mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A29%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topical%20application%20of%20oxifulvic%20acid%20suppresses%20the%20cutaneous%20immune%20response%20in%20mice&rft.jtitle=Drug%20development%20research&rft.au=Van%20Rensburg,%20Constance%20E.J.&rft.date=2001-05&rft.volume=53&rft.issue=1&rft.spage=29&rft.epage=32&rft.pages=29-32&rft.issn=0272-4391&rft.eissn=1098-2299&rft.coden=DDREDK&rft_id=info:doi/10.1002/ddr.1166&rft_dat=%3Cwiley_cross%3EDDR1166%3C/wiley_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3966-3d2d232e74cb03ee507aca7b1dca4cb81a1f20173270a4bd1d58b94ec9361b6f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true